annual CAPEX:
$38.20M+$9.90M(+34.98%)Summary
- As of today (May 29, 2025), NBIX annual capital expenditures is $38.20 million, with the most recent change of +$9.90 million (+34.98%) on December 31, 2024.
- During the last 3 years, NBIX annual CAPEX has risen by +$14.80 million (+63.25%).
- NBIX annual CAPEX is now -28.12% below its all-time high of $53.15 million, reached on December 31, 2004.
Performance
NBIX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$10.70M+$3.40M(+46.58%)Summary
- As of today (May 29, 2025), NBIX quarterly capital expenditures is $10.70 million, with the most recent change of +$3.40 million (+46.58%) on March 31, 2025.
- Over the past year, NBIX quarterly CAPEX has dropped by -$500.00 thousand (-4.46%).
- NBIX quarterly CAPEX is now -55.51% below its all-time high of $24.05 million, reached on March 31, 2004.
Performance
NBIX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$37.70M-$500.00K(-1.31%)Summary
- As of today (May 29, 2025), NBIX TTM capital expenditures is $37.70 million, with the most recent change of -$500.00 thousand (-1.31%) on March 31, 2025.
- Over the past year, NBIX TTM CAPEX has increased by +$6.70 million (+21.61%).
- NBIX TTM CAPEX is now -48.54% below its all-time high of $73.26 million, reached on March 31, 2004.
Performance
NBIX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NBIX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.0% | -4.5% | +21.6% |
| 3 y3 years | +63.3% | +40.8% | +42.3% |
| 5 y5 years | +159.9% | +723.1% | +211.6% |
NBIX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.5% | -7.8% | +729.4% | -1.3% | +144.8% |
| 5 y | 5-year | at high | +250.5% | -7.8% | +729.4% | -1.3% | +309.8% |
| alltime | all time | -28.1% | >+9999.0% | -55.5% | +729.4% | -48.5% | >+9999.0% |
NBIX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $10.70M(+46.6%) | $37.70M(-1.3%) |
| Dec 2024 | $38.20M(+35.0%) | $7.30M(-9.9%) | $38.20M(+5.2%) |
| Sep 2024 | - | $8.10M(-30.2%) | $36.30M(+1.4%) |
| Jun 2024 | - | $11.60M(+3.6%) | $35.80M(+15.5%) |
| Mar 2024 | - | $11.20M(+107.4%) | $31.00M(+9.5%) |
| Dec 2023 | $28.30M(+71.5%) | $5.40M(-28.9%) | $28.30M(+14.6%) |
| Sep 2023 | - | $7.60M(+11.8%) | $24.70M(+60.4%) |
| Jun 2023 | - | $6.80M(-20.0%) | $15.40M(-11.5%) |
| Mar 2023 | - | $8.50M(+372.2%) | $17.40M(+5.5%) |
| Dec 2022 | $16.50M(-29.5%) | $1.80M(-205.9%) | $16.50M(-30.1%) |
| Sep 2022 | - | -$1.70M(-119.3%) | $23.60M(-23.9%) |
| Jun 2022 | - | $8.80M(+15.8%) | $31.00M(+17.0%) |
| Mar 2022 | - | $7.60M(-14.6%) | $26.50M(+13.2%) |
| Dec 2021 | $23.40M(+114.7%) | $8.90M(+56.1%) | $23.40M(+23.2%) |
| Sep 2021 | - | $5.70M(+32.6%) | $19.00M(+38.7%) |
| Jun 2021 | - | $4.30M(-4.4%) | $13.70M(-2.8%) |
| Mar 2021 | - | $4.50M(0.0%) | $14.10M(+29.4%) |
| Dec 2020 | $10.90M(-25.9%) | $4.50M(+1025.0%) | $10.90M(+18.5%) |
| Sep 2020 | - | $400.00K(-91.5%) | $9.20M(-25.2%) |
| Jun 2020 | - | $4.70M(+261.5%) | $12.30M(+1.7%) |
| Mar 2020 | - | $1.30M(-53.6%) | $12.10M(-17.7%) |
| Dec 2019 | $14.70M(-40.7%) | $2.80M(-20.0%) | $14.70M(-17.9%) |
| Sep 2019 | - | $3.50M(-22.2%) | $17.90M(-33.1%) |
| Jun 2019 | - | $4.50M(+15.4%) | $26.76M(-0.5%) |
| Mar 2019 | - | $3.90M(-35.0%) | $26.90M(+8.5%) |
| Dec 2018 | $24.80M(+257.3%) | $6.00M(-51.5%) | $24.80M(+17.1%) |
| Sep 2018 | - | $12.36M(+166.2%) | $21.18M(+82.2%) |
| Jun 2018 | - | $4.64M(+157.9%) | $11.62M(+57.5%) |
| Mar 2018 | - | $1.80M(-24.3%) | $7.38M(+6.3%) |
| Dec 2017 | $6.94M(+68.9%) | $2.38M(-15.2%) | $6.94M(+41.3%) |
| Sep 2017 | - | $2.80M(+606.3%) | $4.91M(+70.3%) |
| Jun 2017 | - | $397.00K(-70.9%) | $2.88M(-39.0%) |
| Mar 2017 | - | $1.36M(+292.5%) | $4.73M(+15.1%) |
| Dec 2016 | $4.11M(+112.4%) | $347.00K(-55.3%) | $4.11M(-10.5%) |
| Sep 2016 | - | $777.00K(-65.4%) | $4.59M(+11.2%) |
| Jun 2016 | - | $2.24M(+202.7%) | $4.13M(+72.4%) |
| Mar 2016 | - | $741.00K(-10.5%) | $2.40M(+23.8%) |
| Dec 2015 | $1.93M(+20.0%) | $828.00K(+162.0%) | $1.93M(+25.2%) |
| Sep 2015 | - | $316.00K(-38.0%) | $1.54M(+3.1%) |
| Jun 2015 | - | $510.00K(+82.1%) | $1.50M(-8.5%) |
| Mar 2015 | - | $280.00K(-36.2%) | $1.64M(+1.6%) |
| Dec 2014 | $1.61M(+195.8%) | $439.00K(+63.2%) | $1.61M(+18.2%) |
| Sep 2014 | - | $269.00K(-58.6%) | $1.36M(+21.1%) |
| Jun 2014 | - | $649.00K(+154.5%) | $1.13M(+52.0%) |
| Mar 2014 | - | $255.00K(+33.5%) | $741.00K(+36.0%) |
| Dec 2013 | $545.00K(-43.9%) | $191.00K(+516.1%) | $545.00K(+37.6%) |
| Sep 2013 | - | $31.00K(-88.3%) | $396.00K(-41.1%) |
| Jun 2013 | - | $264.00K(+347.5%) | $672.00K(+7.3%) |
| Mar 2013 | - | $59.00K(+40.5%) | $626.00K(-35.5%) |
| Dec 2012 | $971.00K(+29.5%) | $42.00K(-86.3%) | $971.00K(+0.2%) |
| Sep 2012 | - | $307.00K(+40.8%) | $969.00K(-20.8%) |
| Jun 2012 | - | $218.00K(-46.0%) | $1.22M(+7.9%) |
| Mar 2012 | - | $404.00K(+910.0%) | $1.13M(+51.2%) |
| Dec 2011 | $750.00K(+138.1%) | $40.00K(-92.9%) | $750.00K(+3.9%) |
| Sep 2011 | - | $562.00K(+339.1%) | $722.00K(+193.5%) |
| Jun 2011 | - | $128.00K(+540.0%) | $246.00K(-26.6%) |
| Mar 2011 | - | $20.00K(+66.7%) | $335.00K(+6.3%) |
| Dec 2010 | $315.00K | $12.00K(-86.0%) | $315.00K(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $86.00K(-60.4%) | $303.00K(+33.5%) |
| Jun 2010 | - | $217.00K(>+9900.0%) | $227.00K(+548.6%) |
| Dec 2009 | $35.00K(-97.4%) | $0.00(-100.0%) | $35.00K(-79.7%) |
| Sep 2009 | - | $10.00K(+900.0%) | $172.00K(-10.4%) |
| Jun 2009 | - | $1000.00(-95.8%) | $192.00K(-82.0%) |
| Mar 2009 | - | $24.00K(-82.5%) | $1.06M(-19.4%) |
| Dec 2008 | $1.32M(+111.9%) | $137.00K(+356.7%) | $1.32M(+0.3%) |
| Sep 2008 | - | $30.00K(-96.6%) | $1.32M(-17.9%) |
| Jun 2008 | - | $874.00K(+211.0%) | $1.61M(+91.2%) |
| Mar 2008 | - | $281.00K(+111.3%) | $840.00K(+34.6%) |
| Dec 2007 | $624.00K(-79.9%) | $133.00K(-58.2%) | $624.00K(+8.1%) |
| Sep 2007 | - | $318.00K(+194.4%) | $577.00K(+6.7%) |
| Jun 2007 | - | $108.00K(+66.2%) | $541.00K(-77.9%) |
| Mar 2007 | - | $65.00K(-24.4%) | $2.45M(-21.1%) |
| Dec 2006 | $3.11M(-57.0%) | $86.00K(-69.5%) | $3.11M(-48.1%) |
| Sep 2006 | - | $282.00K(-86.0%) | $6.00M(-18.8%) |
| Jun 2006 | - | $2.02M(+179.8%) | $7.38M(+14.6%) |
| Mar 2006 | - | $722.00K(-75.7%) | $6.44M(-10.9%) |
| Dec 2005 | $7.24M(-86.4%) | $2.97M(+78.0%) | $7.24M(-26.6%) |
| Sep 2005 | - | $1.67M(+54.9%) | $9.86M(-35.6%) |
| Jun 2005 | - | $1.08M(-28.8%) | $15.31M(-50.0%) |
| Mar 2005 | - | $1.51M(-72.9%) | $30.61M(-42.4%) |
| Dec 2004 | $53.15M(+5.4%) | $5.59M(-21.4%) | $53.15M(-18.2%) |
| Sep 2004 | - | $7.12M(-56.5%) | $64.99M(-5.5%) |
| Jun 2004 | - | $16.38M(-31.9%) | $68.77M(-6.1%) |
| Mar 2004 | - | $24.05M(+37.9%) | $73.26M(+45.2%) |
| Dec 2003 | $50.44M(+851.7%) | $17.44M(+60.0%) | $50.44M(+47.0%) |
| Sep 2003 | - | $10.90M(-47.8%) | $34.31M(+37.6%) |
| Jun 2003 | - | $20.87M(+1591.2%) | $24.93M(+306.0%) |
| Mar 2003 | - | $1.23M(-5.5%) | $6.14M(+15.9%) |
| Dec 2002 | $5.30M(+39.3%) | $1.31M(-14.4%) | $5.30M(+22.1%) |
| Sep 2002 | - | $1.52M(-26.6%) | $4.34M(+6.8%) |
| Jun 2002 | - | $2.08M(+429.8%) | $4.06M(+23.1%) |
| Mar 2002 | - | $392.00K(+13.3%) | $3.30M(-13.3%) |
| Dec 2001 | $3.81M(+55.9%) | $346.00K(-72.3%) | $3.81M(-9.6%) |
| Sep 2001 | - | $1.25M(-5.1%) | $4.21M(+25.4%) |
| Jun 2001 | - | $1.31M(+46.3%) | $3.36M(+20.4%) |
| Mar 2001 | - | $898.00K(+19.4%) | $2.79M(+14.3%) |
| Dec 2000 | $2.44M(+16.2%) | $752.00K(+90.9%) | $2.44M(+36.5%) |
| Sep 2000 | - | $394.00K(-47.2%) | $1.79M(-22.1%) |
| Jun 2000 | - | $746.00K(+36.1%) | $2.29M(+12.0%) |
| Mar 2000 | - | $548.00K(+448.0%) | $2.05M(-2.5%) |
| Dec 1999 | $2.10M(-43.2%) | $100.00K(-88.9%) | $2.10M(-19.2%) |
| Sep 1999 | - | $900.00K(+80.0%) | $2.60M(-16.1%) |
| Jun 1999 | - | $500.00K(-16.7%) | $3.10M(-20.5%) |
| Mar 1999 | - | $600.00K(0.0%) | $3.90M(+5.4%) |
| Dec 1998 | $3.70M(-42.2%) | $600.00K(-57.1%) | $3.70M(-47.1%) |
| Sep 1998 | - | $1.40M(+7.7%) | $7.00M(+22.8%) |
| Jun 1998 | - | $1.30M(+225.0%) | $5.70M(-10.9%) |
| Mar 1998 | - | $400.00K(-89.7%) | $6.40M(0.0%) |
| Dec 1997 | $6.40M(+178.3%) | $3.90M(+3800.0%) | $6.40M(+113.3%) |
| Sep 1997 | - | $100.00K(-95.0%) | $3.00M(-25.0%) |
| Jun 1997 | - | $2.00M(+400.0%) | $4.00M(+66.7%) |
| Mar 1997 | - | $400.00K(-20.0%) | $2.40M(+4.3%) |
| Dec 1996 | $2.30M | $500.00K(-54.5%) | $2.30M(+27.8%) |
| Sep 1996 | - | $1.10M(+175.0%) | $1.80M(+157.1%) |
| Jun 1996 | - | $400.00K(+33.3%) | $700.00K(+133.3%) |
| Mar 1996 | - | $300.00K | $300.00K |
FAQ
- What is Neurocrine Biosciences annual capital expenditures?
- What is the all time high annual CAPEX for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual CAPEX year-on-year change?
- What is Neurocrine Biosciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly CAPEX year-on-year change?
- What is Neurocrine Biosciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM CAPEX year-on-year change?
What is Neurocrine Biosciences annual capital expenditures?
The current annual CAPEX of NBIX is $38.20M
What is the all time high annual CAPEX for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual capital expenditures is $53.15M
What is Neurocrine Biosciences annual CAPEX year-on-year change?
Over the past year, NBIX annual capital expenditures has changed by +$9.90M (+34.98%)
What is Neurocrine Biosciences quarterly capital expenditures?
The current quarterly CAPEX of NBIX is $10.70M
What is the all time high quarterly CAPEX for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly capital expenditures is $24.05M
What is Neurocrine Biosciences quarterly CAPEX year-on-year change?
Over the past year, NBIX quarterly capital expenditures has changed by -$500.00K (-4.46%)
What is Neurocrine Biosciences TTM capital expenditures?
The current TTM CAPEX of NBIX is $37.70M
What is the all time high TTM CAPEX for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM capital expenditures is $73.26M
What is Neurocrine Biosciences TTM CAPEX year-on-year change?
Over the past year, NBIX TTM capital expenditures has changed by +$6.70M (+21.61%)